Home » Topics » BioWorld Science

BioWorld Science
RSS

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

Bile acid reabsorption inhibitors described by Glaxo Wellcome

July 19, 1996

Cathepsin L inhibitors described by Takeda

July 19, 1996

Vitamin D compounds with preferencial calcemic and cell differation inducing activity described

July 19, 1996

Pharmos receives grant to develop loteprednol/tobramycin combination product

July 19, 1996

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

July 19, 1996

Suppressin from pituitary extract described by the University of Alabama

July 19, 1996

Cell-cell adhesion-regulating proteins as antitumor treatment

July 19, 1996

Potent selective protein farnesyltransferase inhibitor from Pierre Fabre

July 19, 1996

Clarion's CPR-1007 shows antitumor, antipsoriatic and antiinflammatory activity

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...